Scientists warn that unless there is an adequate response and proactive measures are taken, society will soon have to deal with direct and indirect effects of the changing climate on human health.
Ozenoxacin, a quinolone antimicrobial drug, works by inhibiting the bacterial DNA replication enzymes, DNA gyrase A and topoisomerase IV.
Intravenous omadacycline and once-per-day oral omadacycline have efficacy and tolerability profiles similar to those of IV and oral linezolid in overweight/obese patients with diabetes and acute bacterial skin and skin structure infection.
Although treating acute bacterial skin and skin structure infections in patients with systemic inflammatory response syndrome can be challenging, dalbavancin is approved by the FDA as an effective treatment.
Narrow-band UV-B phototherapy resulted in statistically significant reductions in clinical scores from weeks 4 through 16.
The median infection-related length of stay for patients treated with ceftaroline fosamil was significantly lower than patients receiving vancomycine; ceftaroline fosamil was also associated with shorter infection-related length of hospital stay even after adjusting for the type of ABSSSI, among other factors
Patients with and without diabetes and acute bacterial skin and skin structure infections experience similar rates of clinical response when treated with dalbavancin.
Choosing between intravenous vs oral antibiotic therapy as well as whether to admit or discharge a patient are 2 common treatment-related decisions emergency medicine providers must make when treating patients with an acute bacterial skin and skin structure infection.
Dermatology Advisor Articles
- Specific Oral Bacteria May Reduce Risk for Squamous Cell Carcinoma
- Ostomy-Related Costs Reduced With Ceramide-Infused Skin Barrier
- Pediatric Psoriasis Associated With Increased Risk for Comorbidity Development
- Improved Neck, Décolletage Lines With Ultrasound, Diluted Calcium Hydroxylapatite
- New Nutrition Science Course Available for Physicians